TY - JOUR
T1 - Safety and efficacy of VMAT2 inhibitors in Huntington Disease
T2 - A systematic review
AU - Baghaei, Ava
AU - Dehnavi, Ali Zare
AU - Hashempour, Zahra
AU - Bordelon, Yvette
AU - Jimenez-Shahed, Joohi
AU - Stimming, Erin Furr
AU - Koch, Jessa
AU - Dashtipour, Khashayar
N1 - Copyright © 2026. Published by Elsevier Ltd.
PY - 2026/4
Y1 - 2026/4
KW - Deutetrabenazine
KW - Huntington disease
KW - Tetrabenazine
KW - VMAT2 inhibitor
KW - Valbenazine
KW - Adrenergic Uptake Inhibitors/pharmacology
KW - Humans
KW - Valine/analogs & derivatives
KW - Huntington Disease/drug therapy
KW - Vesicular Monoamine Transport Proteins/antagonists & inhibitors
KW - Tetrabenazine/analogs & derivatives
UR - https://www.scopus.com/pages/publications/105029598217
UR - https://www.scopus.com/pages/publications/105029598217#tab=citedBy
UR - https://www.mendeley.com/catalogue/70b789bf-c3c1-3a65-ae62-f22f4daf9a68/
U2 - 10.1016/j.parkreldis.2026.108209
DO - 10.1016/j.parkreldis.2026.108209
M3 - Review article
C2 - 41651710
AN - SCOPUS:105029598217
SN - 1353-8020
VL - 145
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
M1 - 108209
ER -